Prognosis
Brazil Reaches Deal to Produce Oxford Covid-19 Vaccine
- Deal includes transfer of technology for local production
- Brazil will spend $287 million on as many as 100 million doses
Commuters wearing protective masks walk inside the Luz train station in Sao Paulo, Brazil, on June 22.
Photographer: Jonne Roriz/BloombergThis article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Brazil, the nation with the second-highest number of coronavirus cases and deaths, reached a deal with the U.K. to produce the Covid-19 vaccine that’s been developed by Oxford University and AstraZeneca Plc.